Listen to the article

0:00
0:00

Celebrities Reveal Weight Loss Journeys in 2025: GLP-1 Medications Take Center Stage

Several high-profile celebrities have made headlines in 2025 for their significant weight loss transformations, with many openly discussing their use of GLP-1 medications like Ozempic and Mounjaro. These weight loss journeys have sparked conversations about health, body image, and the role of prescription medications in managing weight.

The FDA’s recent approval of the first GLP-1 pill for weight loss has further fueled interest in these medications, which were originally developed for diabetes management but have gained popularity for their effectiveness in weight reduction.

Oprah Winfrey, 71, has been particularly vocal about her experience with GLP-1 medications. In a recent exclusive interview with People magazine coinciding with the release of her book “Enough: Your Health, Your Weight and What It’s Like to Be Free,” Winfrey revealed that she began taking a GLP-1 medication in 2023.

After attempting to discontinue the medication six months later, Winfrey gained back 20 pounds despite maintaining her diet and exercise routines. “It’s going to be a lifetime thing,” she explained, comparing it to her blood pressure medication. Winfrey disclosed that her baseline weight of 211 pounds had put her health at risk, as she was pre-diabetic and had high cholesterol.

The media mogul now injects a GLP-1 medication weekly and has even paid out of pocket for friends who couldn’t afford the treatment. Winfrey emphasized that the medication has given her “a quiet strength” by eliminating “food noise” from her life.

Comedian Amy Schumer has lost 50 pounds after being diagnosed with Cushing’s syndrome, a potentially fatal hormonal disorder that causes extreme swelling and fatigue. Responding to online speculation about her dramatic transformation, Schumer clarified in a now-deleted social media post that her weight loss was medically necessary.

“I didn’t lose 30 lbs — I lost 50,” she wrote, confirming that she has used the GLP-1 medication Mounjaro but insisting that her weight loss was “not to look hot” but “to survive.” Schumer also addressed critics by stating, “Sorry for whatever feeling it’s giving you that I lost that weight,” while adding that she’s now “pain-free” and able to actively play with her son.

Singer Meghan Trainor has confronted critics after her own 60-pound weight loss. “I feel great, and that’s when people attack me,” she told “Entertainment Tonight,” noting that the online criticism has only gotten “louder” and “meaner” as her transformation has become more visible.

Trainor’s journey began with eliminating gluten and dairy after discovering she had a “leaky gut.” Her fitness trainer, Bella Maher, revealed that Trainor had already made significant progress through lifestyle changes before introducing a GLP-1 medication. “She did so much of this on her own before ever introducing a GLP-1, and even after starting it, the medication was simply a support, not the reason for her results,” Maher explained.

Musician Lizzo has also debuted a slimmer figure this year, sparking speculation about GLP-1 use. While discussing Ozempic on Trisha Paytas’ podcast in June, Lizzo shared that she had “tried everything” for weight loss but didn’t explicitly confirm using these medications.

Instead, she credited her transformation to switching from a vegan diet to one that includes more meat, which helped her maintain a caloric deficit. “When I started eating whole foods, like beef and chicken and fish, I was actually full and not expanding my stomach,” she explained, adding that her primary motivation was alleviating the back pain she experienced after performances.

These celebrity weight loss stories highlight the complex relationship between health, appearance, and medical interventions. While GLP-1 medications have proven effective for many, they represent just one component of a comprehensive approach to weight management that often includes dietary changes, exercise, and addressing underlying health conditions.

As these medications become more accessible and widely discussed, both celebrities and medical professionals continue to emphasize that they are most effective when used as part of a broader health strategy rather than a quick fix for cosmetic purposes.

Fact Checker

Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.

14 Comments

  1. Elizabeth Brown on

    Oprah’s experience with GLP-1 medications is certainly noteworthy. Her openness about the struggles and need for long-term management could help destigmatize these treatments and encourage more people to explore options that may work for them.

    • Yes, Oprah’s perspective as a highly visible public figure could go a long way in normalizing the use of these medications and the reality of maintaining weight loss over time.

  2. I’m curious to see how the increasing popularity of GLP-1 medications will shape the future of weight management and the public discourse around it. Oprah’s experience highlights both the promise and the challenges of these treatments.

    • Linda N. Lopez on

      Good point. As more people turn to these medications, it will be important to have nuanced conversations that address the complexities and avoid overly simplistic narratives around weight loss.

  3. Patricia Hernandez on

    Oprah’s candid sharing of her journey with GLP-1 medications is commendable. It’s a complex issue, and her openness could help foster more constructive dialogues around weight loss, health, and the role of pharmaceutical interventions.

    • I agree. Oprah’s willingness to be transparent about her experience, including the challenges she faced, is admirable and could go a long way in promoting a more nuanced understanding of these treatments.

  4. Elizabeth Lopez on

    The news about Oprah’s use of GLP-1 medications is certainly thought-provoking. It will be interesting to see how her open discussion of the ups and downs influences public perceptions and the broader conversation around weight management.

    • Absolutely. Oprah’s platform and influence could have a significant impact on how these medications are viewed and utilized. Her willingness to share her personal experiences is valuable in destigmatizing the topic.

  5. James B. Davis on

    The increasing visibility of GLP-1 medications in celebrity weight loss stories is an interesting development. While they can be effective, it’s crucial to consider the long-term implications and ensure these treatments are used responsibly and with proper medical guidance.

    • Amelia Taylor on

      Well said. As these medications become more mainstream, it will be important to have open and informed discussions that address both the benefits and potential risks, and to encourage people to work closely with healthcare professionals in managing their health and weight.

  6. Elizabeth Thompson on

    The rise in celebrity weight loss stories involving GLP-1s raises interesting questions about the role of these medications in the broader health and wellness landscape. While they can be effective, there are still many unknowns around long-term impacts.

    • James Thompson on

      Absolutely. As these medications become more mainstream, it will be important to closely monitor their safety and efficacy, especially for long-term use. Balanced discussions that consider both the benefits and potential risks are crucial.

  7. Interesting to see more celebrities openly discussing their use of weight loss medications like GLP-1s. It highlights the complex nature of weight management and the role these drugs can play, though long-term sustainability is still a concern.

    • Oliver Williams on

      Agreed. It’s good to see more public discourse around the challenges of weight loss and the potential benefits and limitations of these types of medications.

Leave A Reply

A professional organisation dedicated to combating disinformation through cutting-edge research, advanced monitoring tools, and coordinated response strategies.

Company

Disinformation Commission LLC
30 N Gould ST STE R
Sheridan, WY 82801
USA

© 2026 Disinformation Commission LLC. All rights reserved.